Your heart, kidneys, and liver are deeply connected - when one is in trouble, the others feel the strain. Sandy Sommer shares why we believe the WHO’s 5x5 framework for addressing non-communicable diseases (NCDs) should expand to include the kidneys and liver - because protecting one organ means protecting them all. Discover more on why interconnected care matters in our latest report: https://lnkd.in/eq8xWGF7 #LifeForward #ActOnNCDs
Boehringer Ingelheim
Arzneimittelherstellung
Ingelheim am Rhein, Rhineland-Palatinate 2.053.624 Follower:innen
Info
Unsere Mitarbeitenden sind unsere Stärke. Gemeinsam mit über 54.000 Kolleg*innen schaffen wir den nächsten Durchbruch: neue Innovationen für die Gesundheit von Menschen und Tieren. Datenschutzerklärung: https://www.boehringer-ingelheim.com/de/datenschutzerklaerung-0 Impressum: Imprint | Boehringer Ingelheim
- Website
-
http://www.boehringer-ingelheim.com
Externer Link zu Boehringer Ingelheim
- Branche
- Arzneimittelherstellung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Ingelheim am Rhein, Rhineland-Palatinate
- Art
- Privatunternehmen
- Spezialgebiete
- Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals und Contract Manufacturing
Orte
Beschäftigte von Boehringer Ingelheim
-
Eric J. Daza, DrPH, MPS
Associate Director, Biostatistics and Clinical Data Science @ Boehringer Ingelheim ◆ Digital Health N-of-1 Inventor @ Stats-of-1 ◆ JEDI Chair @ ASA ◆…
-
Petri Pohjanen
Driving Digital Evolution at Scale | Harnessing Generative AI for Transformative Results | MBA Candidate
-
Gwen Whitfield Foster
-
Thomas Macauley
Research Data Management - Lab Services Engineer at Boehringer-Ingelheim
Updates
-
The MORE HEALTH for Africa program is designed by our #SocialBusiness initiative in collaboration with Villgro Africa to support innovative social entrepreneurs tackling health disparities across the continent. 👇Meet our latest cohort including companies with established impact, strong operational track record and clear growth trajectories.
We are proud to announce the selected innovators for the MORE HEALTH for Africa Program. This is an exciting group of post-revenue, high-impact social enterprises dedicated to addressing some of Africa’s most pressing health challenges. This initiative, led by Boehringer Ingelheim and Villgro Africa, is designed to accelerate solutions that close health equity gaps. Each company in this cohort has already demonstrated meaningful impact, operational strength, and the potential for significant scale. Swipe through to meet the full cohort and learn more about the incredible work they are doing. AXON Healthtech Abdalrahman Rammah ,BDS 🇵🇸 BioCertica Gert van Wyk Arno Smit Kaaro Health Angella Kyomugisha LifeBank Temie Giwa - Tubosun Dr. Samier Muravvej Livia Health Luvelo Harry VanderWal Echo Nomsa VanderWal Sam Riggleman Medikea Elvis Silayo, MD Valorigo Sarl Daniel Makombe Andrew Gwadiva Immanuel Momanyi Ida Mwangi Edwin Osora
-
#NEWS: Our joint venture AUROBAC THERAPEUTICS enters clinical development with its first sepsis drug candidate, ATX101. This is a major step forward in achieving our ambition to bring innovation to critical care. #ResearchCollaboration #LifeForward
🚨 Key Clinical Milestone Achieved at AUROBAC THERAPEUTICS 🚨 We are proud to announce the successful dosing of the first healthy volunteers in our Phase 1 clinical trial evaluating our sepsis drug candidate, ATX101. ATX101 is a first-in-class treatment, addressing shock, organ failure and mortality in sepsis, a life-threatening condition for which current treatments are limited and often insufficient. This milestone is the result of a strong and productive collaboration with Boehringer Ingelheim, reflecting our shared commitment to developing innovative therapies to tackle urgent unmet medical in patients in critical care settings. 👏 A huge thank you to everyone involved in turning this vision into reality. 👉 https://lnkd.in/eyengUZB #ClinicalTrials #Phase1 #Sepsis #AMR #Biotech #Pharma #Innovation #ATX101 #AUROBAC #MedicalResearch #LifeSciences #DrugDevelopment #HealthcareInnovation #Teamwork
-
-
#PRESS: Peripheral Arterial Disease (PAD) is a complex medical condition that affects over 200 million people worldwide, often leading to severe complications. That's why we're entering into a contract manufacturing agreement with AnGes to advance their gene therapy treatment for PAD patients. This partnership builds on 20 years of collaboration and leverages the microbial manufacturing expertise of our Vienna site. Learn more about this cooperation and our latest milestone in our press release: https://lnkd.in/evpaPTpU #LifeForward #DrugDevelopment #ManufacturingTechnology
-
-
#NEWS: We are addressing the high unmet need in retinal diseases. In partnership with Palatin Technologies we aim to develop a potential first-in-class treatment for diabetic retinopathies. Learn more: https://lnkd.in/era5_YR4 #EyeHealth #DiabeticRetinopathy #Innovation
-
-
“You build a team, you make it work, you feel empowered.” Take a look inside one of our volunteer projects, as Principal System Engineer Ximena Perez explains how digitizing medical records is paving the way for better healthcare in Argentina’s Chaco province 👉 https://lnkd.in/epXsyuD8 We value contributions driven by personal initiative, because we know that they can add up to rising, cumulative change. We support our people who use their ideas, time, and energy to help make millions of lives better.
-
-
#NEWS: The data are in: Our Phase III clinical study met its primary endpoint in people living with the negative symptoms of schizophrenia. The study evaluated the investigational prescription digital therapeutic (PDT) we developed in collaboration with Click Therapeutics, Inc. We extend our gratitude to those who participated in this trial, as these findings will advance our scientific understanding. Learn more: https://lnkd.in/eBMvXikZ #LifeForward
-
-
Take part in our Making More Health Convention on November 5-6. This initiative is focused on co-creating solutions with communities worldwide to become healthy, thriving and self-sustaining. Register to join virtually or onsite in Ingelheim, Germany 👇 #LifeForward #SocialInnovation
Have you registered for Making More Health Together 2025 yet? Hear directly from past attendees why this is the go-to event for social entrepreneurship and impact investment. Join us on November 5–6, 2025, in Ingelheim, Germany or participate virtually - https://lnkd.in/e2QN-Bxi #MakingMoreHealthTogether #ShapingTomorrowBySeedingToday #SocialInnovation
-
#HeartFailure often doesn’t strike alone. 1 in 3 people living with heart failure also have chronic kidney disease—a serious combination that can increase the risk of cardiovascular events. The earlier these connected conditions are detected, the better the outcomes. Don’t wait. Talk to your doctor about your heart and kidney health today to get #TheWholeStory: https://lnkd.in/ePrMECiN #HeartFailureAwareness #LifeForward
If you’re living with #heartfailure, it’s important to regularly monitor your heart health. But for the best outcomes, it’s important to look beyond your heart. Hearts are connected to every other part of our body. So heart failure often develops from, or leads to, other health conditions. People with heart failure often have other conditions at the same time, such as kidney disease, type 2 Diabetes, obesity, high blood pressure, iron deficiency, or an irregular heart rate or rhythm. Mental health conditions like anxiety and depression are also common. These are some of the most common connected conditions, but there are more. It’s important to identify and monitor any connected conditions you might have. So, when you talk to your doctor about your Heart Failure, be sure to talk about everything else that’s connected, too. 🔗 Learn more here: https://lnkd.in/e4yexRF5 #HeartFailure #TheWholeStory #HeartFailureAwareness #HFConnectedConditions hearts4heart Instituto Lado a Lado pela Vida HeartLife Foundation AVEC France Israeli Heart Association Lithuanian Heart Failure Association AADIC-Heart Failure Portuguese Association The Mended Hearts, Inc. WomenHeart: The National Coalition for Women with Heart Disease Croí Heart & Stroke Charity British Society for Heart Failure Heart Failure Warriors NI